Limaca Medical Completes 24 EUS Pancreatic and Liver Biopsy Cases
Limaca’s Precision-GI™ endoscopic ultrasound guided motorized fine needle biopsy (EUS-mFNB) device delivers substantial tissue acquisition.
YOKNEAM, Israel, May 15, 2024 /PRNewswire/ — Limaca Medical (“Limaca”) announced today the successful completion of twenty-four Precision-GI™ endoscopic ultrasound guided motorized fine needle biopsy (EUS-mFNB) cases. Precision-GI’s motorized rotational cutting needle demonstrated significant tissue acquisition. Cases completed by Dr. Carlos Robles-Medranda and colleagues in the ongoing study demonstrate that Precision-GI is quickly and efficiently obtaining contiguous intact core tissue samples for definitive diagnosis of target tissues. Dr. Robles-Medranda is Head of the Endoscopy Division, Ecuadorian Institute of Digestive Diseases, Guayaquil, Ecuador. Precision-GI™ has received FDA Clearance and Breakthrough Device Designation.
Related news for (TRNLY)
- Dasyo Welcomes Medical Aesthetics Industry Icon Domenic (Dom) Serafino as Executive Chair
- Ceretrieve Announces Groundbreaking Success in FIH Ischemic Stroke Cases
- ZygoFix Receives FDA Clearance for its zLOCK Lumbar Facet Fixation System
- Vessi Medical Closes $16.5 Million Series A Round for Innovative Cryotherapy Bladder Cancer Treatment